Literature DB >> 10395840

Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection.

L K Musey1, J N Krieger, J P Hughes, T W Schacker, L Corey, M J McElrath.   

Abstract

Without potent antiretroviral therapy, most human immunodeficiency virus type 1 (HIV-1)-infected persons experience a progressive decline in CD4+ T cells and impairment in T helper function. It is unclear how soon after infection T cell dysfunction occurs. T helper responses were examined in blood and lymphoid tissue of 39 untreated patients with acute HIV-1 infection. Within the first 3 months, lymphoproliferative responses to mitogen, recall antigens, and HIV-1 antigens were impaired. After 6-9 months, responses to phytohemagglutinin and recall antigens improved. However, HIV-1-specific lymphoproliferation remained largely undetectable throughout 2 years of infection, and results were similar upon evaluation of lymphoid cells. Rare patients with HIV-1-specific responses had significantly lower plasma HIV-1 RNA levels than did nonresponders. These results indicate that T helper dysfunction occurs early after HIV-1 acquisition and that untreated individuals rarely recover HIV-specific helper responses; these findings lend support for early therapeutic intervention to prevent the destruction and further impairment of the T helper cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395840     DOI: 10.1086/314868

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-gamma-producing memory CD4+ T cells.

Authors:  V Pancré; B Georges; G Angyalosi; F Castelli; A Delanoye; M Delacre; E Hachulla; B Maillere; A Bouzidi; C Auriault
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

Review 2.  The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression.

Authors:  C Farquhar; G John-Stewart
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

3.  Impact of opportunistic Mycobacterium tuberculosis infection on the phenotype of peripheral blood T cells of AIDS patients.

Authors:  Germán Bernal-Fernández; Carlos Hermida; Patricia Espinosa-Cueto; Ana Cristina Cubilla-Tejeda; Jesús Fidel Salazar-González; Librado Ortiz-Ortiz; Rosario Leyva-Meza; Hugo Diaz-Silvestre; Raul Mancilla
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

4.  Cross-reactive T-helper responses in patients infected with different subtypes of human immunodeficiency virus type 1.

Authors:  A C Leandersson; G Gilljam; M Fredriksson; J Hinkula; A Alaeus; K Lidman; J Albert; G Bratt; E Sandström; B Wahren
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 5.  HIV persistence: chemokines and their signalling pathways.

Authors:  Vanessa A Evans; Gabriela Khoury; Suha Saleh; Paul U Cameron; Sharon R Lewin
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-28       Impact factor: 7.638

6.  Differential expression of interleukin-2 and gamma interferon in human immunodeficiency virus disease.

Authors:  S F Sieg; D A Bazdar; C V Harding; M M Lederman
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120.

Authors:  C E Hioe; M Tuen; P C Chien; G Jones; S Ratto-Kim; P J Norris; W J Moretto; D F Nixon; M K Gorny; S Zolla-Pazner
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  HIV-induced changes in T cell signaling pathways.

Authors:  Marc Schweneker; David Favre; Jeffrey N Martin; Steven G Deeks; Joseph M McCune
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

9.  Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population.

Authors:  Eirik A Torheim; Lishomwa C Ndhlovu; Frank O Pettersen; Trine-Lise Larsen; Aashish R Jha; Knut M Torgersen; Dag Kvale; Douglas F Nixon; Kjetil Taskén; Einar M Aandahl
Journal:  Eur J Immunol       Date:  2009-05       Impact factor: 5.532

10.  Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection.

Authors:  Uma Malhotra; Sarah Holte; Tuofu Zhu; Elizabeth Delpit; Claire Huntsberry; Alessandro Sette; Raj Shankarappa; Janine Maenza; Lawrence Corey; M Juliana McElrath
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.